COSCIENS Biopharma Inc T.AEZS

Merger Concessions

[oats]

At the time of the merger concessions, we were assured that a succession plan was already in place and that a replacement search for Gilles Gagnon had begun.

I have no idea where that stands as there were disagreements with regards to the "Merger of Equals" after the AEZS first quarter cash position was stated.

[prophetoffactz]

"AEZS first quarter cash position was stated." The more interesting question is what is the interest in licensing the diagnostic test. July 2023 AEZS said in a news release: "Further, based upon our active outreach and discussions, we expect to secure an alternate development and commercialization partner for Macrilen® for the U.S. and Canada.” Gilles would have known

[Hopeforthebest]

First you entioned that gagnon promised to resign which is significantly different from a succession plan. Secondly, if gagnon did not know what the first quarter cash situation was long before it was reveled there is something wrong with this person. You where fed a line, piled high and deep. Unfortunately your trust placed in gagnon beingopen and  thruthful was misguided and now we all

[tigerpro]

Oat, please check your message box. 

[tigerpro]

Oat,   replied just now.  please check your message box again.  Thanks.